2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Tempero Bio, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Interaction Between TMP-301 and Cocaine. TMP-301, Placebo - Cocaine Use Disorder | Phase 1 | Completed | Tempero Bio, Inc. | 18 | 2025-01-04 | 2025-05-18 |
| A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder TMP-301, Placebo - Alcohol Use Disorder (AUD) | Phase 2 | Terminated | Tempero Bio, Inc. | 110 | 2024-11-14 | 2026-04-13 |
| Multiple Ascending Dose Study of TMP-301 in Healthy Subjects Cohort 1 - TMP-301, Placebo, Cohort 2 - TMP-301 - Cocaine Use Disorder, Substance Use Disorders | Phase 1 | Completed | Tempero Bio, Inc. | 30 | 2023-01-06 | 2025-07-29 |
Substance-Related Disorders (3) · Alcoholism (1) · Systemic carnitine deficiency (1)
United States (3)
Dan Meyers, MD (1)
U01DA057118 (1)